% Expired Patents = 40.0

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 104

Loading Chart...

4 inventors (with patents filed for the assignee):

Cedric Francois (5 out of 43 patents)

Pascal Deschatelets (5 out of 31 patents)

Paul Olson (5 out of 24 patents)

4. Alec Machiels (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 9056076 - Method of treating age-related macular degeneration comprising administering a compstatin analog (2015-06-16),

2. 8198020 - Compositions and methods for enhancing phagocytosis or phagocyte activity (2012-06-12),

3. 8168584 - Methods of treating age-related macular degeneration by compstatin and analogs thereof (2012-05-01),

4. 8043609 - Viral complement control proteins for eye disorders (2011-10-25),

5. 7947267 - Viral complement control proteins for eye disorders (2011-05-24),

Company Overview

Potentia Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of rare genetic disorders. With a strong pipeline of potential therapeutics, Potentia is dedicated to improving the lives of patients with unmet medical needs. By leveraging innovative research and cutting-edge technology, the company aims to bring new hope to those affected by these rare diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#2 in Crestwood, KY

#276 in Kentucky

#51,570 in US

Crestwood, KY, United States of America

Potentia Pharmaceuticals, Inc.

Forward Citations = 104

4 inventors:

Cedric Francois (5 out of 43 patents)

Pascal Deschatelets (5 out of 31 patents)

Paul Olson (5 out of 24 patents)

4. Alec Machiels (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Potentia Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/potentia-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]